Role of Efferocytosis in Health and Diseases
-
Published:2024-05-18
Issue:1
Volume:2024
Page:1-12
-
ISSN:2816-8119
-
Container-title:Albus Scientia
-
language:
-
Short-container-title:Albus Scientia
Author:
Abbasi Muddasir HORCID, Shehzadi NimraORCID, Safdar AroojORCID, Aslam Rabia, Tariq Arsha, Shahid Misbah, Zafar AzkaORCID, Sheikh NadeemORCID, Khawar Muhammad BabarORCID
Abstract
Efferocytosis is the process of removal of apoptotic cells through phagocytosis by the specialized cells known as efferocytes. Clearance of dead cells also plays an important role in the defensive system of organisms as efferocytosis maintains homeostasis and repairing of tissues and organs. In this process, the dying cell releases signals for identification and engulfment which is further processed by macrophages. Efferocytosis prevents the secondary necrosis and release of pro-inflammatory cellular contents. This clearance process involves interplay of signaling molecules, receptors, and other mediators that ensures prompt recognitions and removal of dying cells. Dysregulation of efferocytosis has been implicated in various pathological conditions, including autoimmune diseases, chronic inflammation, and atherosclerosis. This review focuses on some common autoimmune diseases, cardiovascular diseases, respiratory disorders, and neurodegenerative disorders due to impaired efferocytosis. To describe the pathophysiology of efferocytosis in diseases more extensive studies are required.
Publisher
Albus Scientific Inc.
Reference106 articles.
1. Abram, C. L., & Lowell, C. A. (2017). Shp1 function in myeloid cells. Journal of Leukocyte Biology,102(3). https://doi.org/10.1189/jlb.2mr0317-105r 2. Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., & Weissman, I. L. (2019). CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature, 572(7769). https://doi.org/10.1038/s41586-019-1456-0 3. Barkal, A. A., Weiskopf, K., Kao, K. S., Gordon, S. R., Rosental, B., Yiu, Y. Y., George, B. M., Markovic, M., Ring, N. G., Tsai, J. M., McKenna, K. M., Ho, P. Y., Cheng, R. Z., Chen, J. Y., Barkal, L. J., Ring, A. M., Weissman, I. L., & Maute, R. L. (2018). Engagement of MHC class i by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy article. Nature Immunology, 19(1). https://doi.org/10.1038/s41590-017-0004-z 4. Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020). The clearance of dead cells by efferocytosis. In Nature Reviews Molecular Cell Biology, 21( 7). https://doi.org/10.1038/s41580-020-0232-1 5. Brown, S., Heinisch, I., Ross, E., Shaw, K., Buckley, C. O., & Savill, J. (2002). Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature, 418, 6894. https://doi.org/10.1038/nature00811
|
|